Joana B. Infante

Santa Maria, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Improved real-world outcomes of patients with acute promyelocytic leukaemia treated with first-line arsenic trioxide in specialized centres in Portugal through a 24/7 phone-based referral.

Improved real-world outcomes of patients with acute promyelocytic leukaemia treated with first-line arsenic trioxide in specialized centres in Portugal through a 24/7 phone-based referral.

Journal: British journal of haematology

Published: March 03, 2026

Predictors of Early Death in Acute Promyelocytic Leukemia.

Predictors of Early Death in Acute Promyelocytic Leukemia.

Journal: Medical sciences (Basel, Switzerland)

Published: September 23, 2025

Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study.

Treatment patterns and outcomes in secondary acute myeloid leukemia arising after hypomethylating agents: PETHEMA registry study.

Journal: Cancer

Published: August 07, 2024

Case report: VEXAS syndrome: an atypical indolent presentation as sacroiliitis with molecular response to azacitidine.

Case report: VEXAS syndrome: an atypical indolent presentation as sacroiliitis with molecular response to azacitidine.

Journal: Frontiers in immunology

Published: March 19, 2024

Disseminated intravascular coagulation score evolution in 48 h predicts early death in acute promyelocytic leukemia patients.

Disseminated intravascular coagulation score evolution in 48 h predicts early death in acute promyelocytic leukemia patients.

Journal: European journal of haematology

Published: October 21, 2023

Cerebral venous thrombosis as a first presentation of a high-risk acute myeloid leukaemia.

Cerebral venous thrombosis as a first presentation of a high-risk acute myeloid leukaemia.

Journal: Acta neurologica Belgica

Published: September 25, 2023

Full-Dose Azacitidine in 5 Days Versus 7 Days With a Weekend Break in Myelodysplastic Syndromes: A Retrospective Cohort Study.

Full-Dose Azacitidine in 5 Days Versus 7 Days With a Weekend Break in Myelodysplastic Syndromes: A Retrospective Cohort Study.

Journal: Clinical lymphoma, myeloma & leukemia

Published: April 24, 2023

Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study.

Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study.

Journal: Annals of hematology

Published: April 09, 2023

Cerebrovascular Complications of Anemia.

Cerebrovascular Complications of Anemia.

Journal: Current neurology and neuroscience reports

Published: July 03, 2021

Cerebrovascular manifestations in hematological diseases: an update.

Cerebrovascular manifestations in hematological diseases: an update.

Journal: Journal of neurology

Published: January 12, 2021

Spontaneous Tumor Lysis Syndrome: A Rare Presentation in Plasmablastic Lymphoma.

Spontaneous Tumor Lysis Syndrome: A Rare Presentation in Plasmablastic Lymphoma.

Journal: Journal of hematology

Published: March 13, 2020

Correction to: Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus.

Correction to: Update on management and progress of novel therapeutics for R/R AML: an Iberian expert panel consensus.

Journal: Annals of hematology

Published: February 01, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026